These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2778853)

  • 1. Mutagenicity tests on propiverine hydrochloride.
    Ohuchida A; Furukawa A
    J Toxicol Sci; 1989 May; 14(2):131-41. PubMed ID: 2778853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity tests of mofezolac (N-22).
    Ohuchida A; Furukawa A
    J Toxicol Sci; 1990 Jun; 15 Suppl 2():239-51. PubMed ID: 2231792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutagenicity tests of suplatast tosilate (IPD-1151T)].
    Ohuchida A; Furukawa A; Sato S; Maeda Y; Kashihara A; Mizumoto T; Yoshida R
    J Toxicol Sci; 1992 May; 17 Suppl 2():207-20. PubMed ID: 1321262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
    Ohuchida A; Kouchi Y; Sato S; Maeda Y
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Ohuchida A; Taniguti A; Kouchi Y; Maeda Y; Kashihara A; Omae S
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Tamura H; Yamashita Y; Kitayama E; Iwakura K; Watanabe M; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():263-74. PubMed ID: 9170614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394)].
    Iwakura K; Tamura H; Yamashita Y; Watanabe M; Sumi N; Shindo Y; Ando M; Kojima M
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():241-57. PubMed ID: 8709165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
    Kondo K; Takase S; Nishimoto Y; Miyajima H; Shiratori O; Miyake Y
    J Toxicol Sci; 2001 May; 26 Suppl 1():243-54. PubMed ID: 11400316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutagenicity studies of (+/-)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Otsuka M; Kajiwara Y; Ajimi S; Shimazaki H; Kikuno T; Ogura S; Inai T; Kakimoto K; Tamura H; Watanabe M; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():251-61. PubMed ID: 9170613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity test of cefodizime sodium.
    Ohuchida A; Yoshida R
    J Toxicol Sci; 1988 Jun; 13 Suppl 1():245-56. PubMed ID: 3050144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity assessment of pirmenol, a new antiarrhythmic drug.
    Ciaravino V; Kropko ML; Krishna G; Monteith DK; Theiss JC
    Mutat Res; 1992; 280(3):205-14. PubMed ID: 1381484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse mutation tests in Salmonella typhimurium and chromosomal aberration tests in mammalian cells in culture on fluorinated pyrimidine derivatives.
    Yajima N; Kondo K; Morita K
    Mutat Res; 1981 Mar; 88(3):241-54. PubMed ID: 6454840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutagenicity studies of montirelin hydrate (NS-3)].
    Iwakura K; Tamura H; Yamashita Y; Kitayama E; Hamasu Y; Nagasawa H; Watanabe M; Sumi N
    J Toxicol Sci; 1995 Dec; 20 Suppl 2():325-34. PubMed ID: 9019565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxicity evaluation of Hwanglyeonhaedok-tang, an herbal formula.
    Jin SE; Lee MY; Seo CS; Ha H; Kim JY; Shin HK
    J Ethnopharmacol; 2017 Apr; 202():122-126. PubMed ID: 27916588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity studies on fenitrothion in bacteria and mammalian cells.
    Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J
    Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent.
    Hirai O; Miyamae Y; Hattori Y; Takashima M; Miyamoto A; Zaizen K; Mine Y
    Mutat Res; 1994 Jun; 324(1-2):43-50. PubMed ID: 7515469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutagenicity studies of magnesium sulfate--reverse mutation test with bacteria and chromosomal aberration test with mammalian cells in culture].
    Oguma Y; Yokota F; Inoue K; Shimamura K
    J Toxicol Sci; 1998 May; 23 Suppl 1():81-90. PubMed ID: 9617738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic properties of 2-amino-N6-hydroxyadenine in Salmonella and in Chinese hamster lung cells in culture.
    Nagao M; Nakayasu M; Aonuma S; Wakabayashi K; Hirose M; Sugimura T
    Mutat Res; 1991 Aug; 253(1):97-102. PubMed ID: 1870613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity studies with palm fruit carotene.
    Masuda M; Haresaku M; Takei T; Nakamura T
    J Toxicol Sci; 1995 Nov; 20(5):619-27. PubMed ID: 8720168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.